Have a personal or library account? Click to login
Obesity Impact on Respiratory Function Cover

Obesity Impact on Respiratory Function

Open Access
|Mar 2021

References

  1. 1. Joan B Soriano & al, Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 19902015: a systematic analysis for the Global Burden of Disease Study 2015, GBD 2015 Chronic Respiratory Disease Collaborators, Lancet Respir Med 2017; 5: 691706
  2. 2. Heng He, Bin Wang, Min Zhou, Limin Cao, Weihong Qiu, Ge Mu, Ailian Chen,Shijie Yang,Weihong Chen,Systemic Inflammation Mediates the Associations Between Abdominal Obesity Indices and Lung Function Decline in a Chinese General Population Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020:13 141150 14110.2147/DMSO.S229749698085032021360
  3. 3. Robert Ross, Ian J. Neeland, Shizuya Yamashita, Iris Shai, Jaap Seidell,Paolo Magni, Raul D. Santos, Benoit Arsenault, Ada Cuevas, Frank B. Hu, Bruce A. Griffin, Alberto Zambon, Philip Barter, Jean- Charles Fruchart, Robert H. Eckel, Yuji Matsuzawa and Jean-Pierre Després, Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity, Nature reviews Endocrinology, published online, 04th of February 2020
  4. 4. Gabriela P. Peralta GP, et al. Body mass index and weight change are associated with adult lung function trajectories: the prospective ECRHS studyThorax 2020
  5. 5. Zammit C, Liddicoat H, Moonsie I, et al. Obesity and respiratory diseases. Am J Clin Hypn 2011; 53:33543.
  6. 6. Anca Hâncu; Nutritional status as a risk factor in COPD-state of the art; Maedica- a Journal of Clinical Medicine, 2019; 14(2): 140-143.10.26574/maedica.2019.14.2.140
  7. 7. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017;49(3):170021410.1183/13993003.00214-201728182564
  8. 8. Ref Paradox: Yilan Sun, Stephen Milne, Jen Erh Jaw, Chen Xi Yang, Feng Xu, Xuan Li, Ma’en Obeidat and Don D. Sin, BMI is associated with FEV1 decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trial, Respiratory Research (2019) 20:23610.1186/s12931-019-1209-5681952231665000
  9. 9. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir CritCare Med. 1999;160(6):185661.10.1164/ajrccm.160.6.990211510588597
  10. 10. Schols AMWJ, Slangen J, Volovics L, Wouters EFM. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(6):17917.10.1164/ajrccm.157.6.9705017
  11. 11. Hasegawa W, Yamauchi Y, Yasunaga H, Sunohara M, Jo T, Matsui H, et al. Factors affecting mortality following emergency admission for chronic obstructive pulmonary disease. BMC Pulm Med. 2014;14:151.10.1186/1471-2466-14-151419282625253449
  12. 12. Gudmundsson G, Ulrik CS, Gislason T, Lindberg E, Brondum E, Bakke P, et al. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. Int J Chron Obstruct Pulmon Dis. 2012;7:5716.
  13. 13. Pelosi P, Croci M, Ravagnan I, et al. The effects of body mass on lung volumes, respiratory mechanics, and gas exchange during general anesthesia. Anesth Analg 1998 9;87(3):6546010.1213/00000539-199809000-00031
  14. 14. Hedenstierna G, Santesson J. Breathing mechanics, dead space and gas exchange in the extremely obese, breathing spontaneously and during anaesthesia with intermittent positive pressure ventilation. Acta Anaesthesiol Scand 1976;20(3):2485410.1111/j.1399-6576.1976.tb05036.x785930
  15. 15. Sharp JT, Henry JP, Sweany SK, et al. The total work of breathing in normal and obese men. J Clin Invest 1964 4;43:7283910.1172/JCI10495728954914149924
  16. 16. Ferretti A, Giampiccolo P, Cavalli A, et al. Expiratory flow limitation and orthopnea in massively obese subjects. Chest 2001 5;119(5):1401810.1378/chest.119.5.140111348945
  17. 17. Sin DD, Jones RL, Man SF. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med 2002 7;162(13):14778110.1001/archinte.162.13.147712090884
  18. 18. Schachter LM, Salome CM, Peat JK, et al. Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness. Thorax 2001 1;56(1):48. (PubMed: 11120896)10.1136/thorax.56.1.4174591911120896
  19. 19. Sugerman H, Windsor A, Bessos M, et al. Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity. J Intern Med 1997 1;241(1):71910.1046/j.1365-2796.1997.89104000.x9042096
  20. 20. Behazin N, Jones SB, Cohen RI, et al. Respiratory restriction and elevated pleural and esophageal pressures in morbid obesity. J Appl Physiol (1985) 2010 1;108(1):212810.1152/japplphysiol.91356.2008288507319910329
  21. 21. Pelosi P, Croci M, Ravagnan I, et al. Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly obese patients. Chest 1996 1;109(1):14451.10.1378/chest.109.1.1448549177
  22. 22. Ubong Peters and Anne E. Dixon, The effect of obesity on lung function, Expert Rev Respir Med. 2018 September ; 12(9): 755767.10.1080/17476348.2018.1506331631138530056777
  23. 23. Sideleva O, Suratt BT, Black KE, et al. Obesity and asthma: an inflammatory disease of adipose tissue not the airway. American journal of respiratory and critical care medicine 2012 101;186(7):598605.10.1164/rccm.201203-0573OC348052222837379
  24. 24. Polotsky VY, Smaldone MC, Scharf MT, et al. Impact of interrupted leptin pathways on ventilatory control. J Appl Physiol (1985) 2004 3;96(3):9918.10.1152/japplphysiol.00926.200314578371
  25. 25. Bassi M, Furuya WI, Menani JV, et al. Leptin into the ventrolateral medulla facilitates chemorespiratory response in leptin-deficient (ob/ob) mice. Acta Physiol (Oxf) 2014 5;211(1):2408.10.1111/apha.12257436578324521430
  26. 26. Torday JS, Powell FL, Farmer CG, et al. Leptin integrates vertebrate evolution: from oxygen to the blood-gas barrier. Respir Physiol Neurobiol 2010 8 31;173 Suppl:S3742.10.1016/j.resp.2010.01.007405950220096383
  27. 27. De Blasio MJ, Boije M, Kempster SL, et al. Leptin Matures Aspects of Lung Structure and Function in the Ovine Fetus. Endocrinology 2016 1;157(1):395404.10.1210/en.2015-1729470189426479186
  28. 28. VLaVT J. Mediation analysis allowing for exposure-mediator interactions SAS and SPSS macros. Psychol Methods. 2013;18(2):137150. doi:10.1037/a003103410.1037/a0031034365919823379553
  29. 29. Frohlich M, Imhof A, Berg G, et al. Association between C-reactive protein and features of the metabolic syndrome a population-based study. Diabetes Care. 2000;23(12):18351839.10.2337/diacare.23.12.183511128362
  30. 30. Vatrella A, Calabrese C, Mattiello A, et al. Abdominal adiposity is an early marker of pulmonary function impairment: findings from a mediterranean Italian female cohort. Nutr Metab Cardiovasc Dis. 2016;26(7):643648. doi:10.1016/j.numecd.2015.12.01310.1016/j.numecd.2015.12.01327107841
  31. 31. Sin DD, Jones RL, Man SFP. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med. 2002;162(13):1477.10.1001/archinte.162.13.147712090884
  32. 32. Fogarty AW, Lewis SA, McKeever TM, Britton J. The association of two different measures of body habitus with lung function: a population-based study. Respir Med. 2011;105(12):18961901.10.1016/j.rmed.2011.07.02421920727
  33. 33. Pistelli F, Bottai M, Carrozzi L, et al. Changes in obesity status and lung function decline in a general population sample. Respir Med. 2008;102(5):674680.10.1016/j.rmed.2007.12.02218261894
  34. 34. Agrawal A, Mabalirajan U, Ahmad T, et al. Emerging interface between metabolic syndrome and asthma. Am J Respir Cell Mol Biol 2011 3;44(3):2705. doi: 10.1165/rcmb.2010-0141TR.10.1165/rcmb.2010-0141TR20656947
  35. 35. Dekkers BG, Schaafsma D, Tran T, et al. Insulin-induced laminin expression promotes a hypercontractile airway smooth muscle phenotype. Am J Respir Cell Mol Biol 2009 10;41(4):494504.10.1165/rcmb.2008-0251OC19213874
  36. 36. Scarlata S, Fimognari FL, Cesari M, et al. Lung function changes in older people with metabolic syndrome and diabetes. Geriatr Gerontol Int 2013 10;13(4):894900. doi: 10.1111/ggi.12026.10.1111/ggi.1202623311827
  37. 37. Fimognari FL, Pasqualetti P, Moro L, et al. The association between metabolic syndrome and restrictive ventilatory dysfunction in older persons. J Gerontol A Biol Sci Med Sci 2007 7;62(7):76010.1093/gerona/62.7.76017634324
  38. 38. Jha P., The hazards of smoking and the benefits of cessation: a critical summation of the epidemiological evidence in high-income countries.,Elife. 2020 Mar 24;9.10.7554/eLife.49979709310932207405
  39. 39. Mercado N, Ito K, Barnes PJ. Accelerated ageing of the lung in COPD: new concepts. Thorax 2015;70:4829.10.1136/thoraxjnl-2014-20608425739910
  40. 40. Pascal Andujar, Dominique Courbon, Emilie Bizard, Elisabeth Marcos, Serge Adnot, Laurent Boyer, Pascal Demoly, Debbie Jarvis, Catherine Neukirch, Isabelle Pin, Gabriel Thabut, Jorge Boczkowski, Bénédicte Leynaert -Smoking, telomere length and lung function decline: a longitudinal population based study Thorax Published Online First Accepted 8 May 2017 Thorax 2017;0:13.10.1136/thoraxjnl-2017-21029428724638
  41. 41. Salvi, S.S., Brashier, B.B., Londhe, J. et al. Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease. Respir Res 21, 50 (2020).10.1186/s12931-020-1310-9701752132050955
  42. 42. Sposato B, Scalese M, Milanese M, Scichilone N, Scala R, Perrella A- Smoking and Obesity Increase Airway Hyperesponsiveness Risk in the Elderly, Curr Aging Sci. 2016;9(4):284-294.)10.2174/187460980966616041311360427071476
  43. 43. Sadeghimakki, R., & McCarthy, D. (2019). Interactive effects of adiposity and insulin resistance on the impaired lung function in asthmatic adults: cross-sectional analysis of NHANES data. Annals of Human Biology, 121.10.1080/03014460.2019.157222330712386
  44. 44. Lee, J. H., Lee, H. S., & Lee, Y. J. Lung function as a predictor of incident type 2 diabetes in community-dwelling adults: A longitudinal finding over 12 years from the Korean Genome and Epidemiology Study. Diabetes & Metabolism, 2019.12.005.10.1016/j.diabet.2019.12.00531884177
  45. 45. Grant, T., Brigham, E. P., & McCormack, M. C. Childhood Origins of Adult Lung Disease as Opportunities for Prevention. The Journal of Allergy and Clinical Immunology: In Practice,2020, 8(3), 84985810.1016/j.jaip.2020.01.015765354432147138
  46. 46. Meo SA, Ansary MA, Barayan FR, Almusallam AS, Almehaid AM, Alarifi NS, Alsohaibani TA, Zia I,Electronic Cigarettes: Impact on Lung Function and Fractional Exhaled Nitric Oxide Among Healthy Adults. Am J Mens Health. 2019 Jan-Feb; 13(1)10.1177/1557988318806073677113030318975
  47. 47. Altered lung biology of healthy never smokers following acute inhalation of E-cigarettes.Staudt MR, Salit J, Kaner RJ, Hollmann C, Crystal RG,Respir Res. 2018 May 14; 19(1):7810.1186/s12931-018-0778-z595017729754582
  48. 48. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R.- 21st-century hazards of smoking and benefits of cessation in the United States.N Engl J Med. 2013 Jan 24;368(4):341-5010.1056/NEJMsa121112823343063
  49. 49. Elaine Fuertesa, Iana Markevyche, Deborah Jarvisd, Danielle Vienneauh, Kees de Hooghh, Josep Maria Antóa, Gayan Bowattej, Roberto Bonok, Angelo G. Corsicol, Margareta Emtnern, Thorarinn Gislasono, José Antonio Gullónp, Joachim Heinrichd, John Hendersonq, Mathias Holmr, Ane Johannessens, Bénédicte Leynaertu, Alessandro Marconw, Pierpaolo Marchettiw, Jesús Martínez Moratallax, Silvia Pascualaa, Nicole Probst-Henschh, José Luis Sánchez-Ramosac, Valerie Sirouxad, Johan Sommarae, Joost Weyleraf, Nino Kuenzlih,i, Bénédicte Jacquemina, Judith Garcia-Aymericha, Residential air pollution does not modify the positive association between physical activity and lung function in current smokers in the ECRHS study, Environment International 120 (2018) 364-37210.1016/j.envint.2018.07.03230121517
  50. 50. Brumpton, B.M., Langhammer, A., Henriksen, A.H., Camargo, C.A., Chen, Y., Romundstad, P.R., et al., 2017. Physical activity and lung function decline in adults with asthma: the HUNT Study. Respirology 22, 278283.10.1111/resp.1288427696634
  51. 51. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2015. Available from URL: www.ginasthma.org
  52. 52. Hayley Lewthwaite, Tanja W Effing, Timothy Olds and Marie T Williams, Physical activity, sedentary behaviour and sleep in COPD guidelines: A systematic review, Chronic Respiratory Disease 2017, Vol. 14(3) 23124410.1177/1479972316687224572023628774202
  53. 53. French Language Pneumology Society. (Recommendation for clinical practice management of COPD). Rev Mal Respir 2010; 27: 522548.
  54. 54. Gupta D, Agarwal R, Aggarwal AN, et al. Guidelines for diagnosis and management of chronic obstructive pulmonary disease: joint ICS/NCCP (I) recommendations. Lung India 2013; 30: 22826710.4103/0970-2113.116248377521024049265
  55. 55. Ministry of Health Malaysia, Academy of Medicine Malaysia, Malaysian Thoracic Society. Management of chronic obstructive pulmonary disease, http://www.moh.gov.my/attachments/4749.pdf (2009, accessed 29 April 2016).
  56. 56. Miravitlles M, Soler-Catalun ˜a JJ, Calle M, et al. Spanish guideline for COPD (GesEPOC). Update 2014. Arch Broncopneumol 2014; 50: 116. 2017, Vol. 14(3) 231244
  57. 57. 57. The Institute for Healthcare Improvement CBO. (Guideline for the diagnosis and treatment of COPD update March 2010), http://www.nvalt.nl/uploads/Mn/U9/MnU99pqRBYK7a_zStHhumA/Richtlijn-Diagnostieken-behandeling-van-COPD-maart-2010.pdf (2010, accessed 27 April 2016).
  58. 58. Danish Health Authority. (COPD - Chronic obstructive pulmonary disease: Recommendations for early detection, monitoring, treatment and rehabilitation), http://www.sst.dk/~/media/F6A8B61402814D59836C0CE6C710E732.ashx (2007, accessed 29 April 2016).
  59. 59. Fuertes E, Carsin A-E, Antó JM, et al. Leisure-time vigorous physical activity is associated with better lung function: the prospective ECRHS study. Thorax 2018;73:37684.10.1136/thoraxjnl-2017-210947587046229306902
  60. 60. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:45863.10.1164/rccm.200607-896OC17158282
  61. 61. Gan, W.Q., Man, S.F.P., Sin, D.D., 2005. The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest 127, 558564.10.1378/chest.127.2.55815705996
  62. 62. Kasapis, C., Thompson, P.D., 2005. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J. Am. Coll. Cardiol. 45,1563156910.1016/j.jacc.2004.12.07715893167
  63. 63. Wang M-L,McCabe L, Petsonk EL, et al. Weight gain and longitudinal changes in lung function in steel workers. Chest 1997;111:152632.10.1378/chest.111.6.1526
  64. 64. Bottai M, Pistelli F, Di Pede F, et al. Longitudinal changes of body mass index,spirometry and diffusion in a general population. Eur Respir J 2002;20:66573.10.1183/09031936.02.0128200112358345
  65. 65. Carey IM, Cook DG, Strachan DP. The effects of adiposity and weight change on forced expiratory volume decline in a longitudinal study of adults. Int J Obes 1999;23:97985.10.1038/sj.ijo.0801029
  66. 66. Chen Y, Horne SL, Dosman JA. Body weight and weight gain related to pulmonary function decline in adults: a six year follow up study. Thorax 1993;48:37580.10.1136/thx.48.4.375
  67. 67. Chinn DJ, Cotes JE, Reed JW. Longitudinal effects of change in body mass on measurements of ventilatory capacity. Thorax 1996;51:699704.10.1136/thx.51.7.699
  68. 68. Chinn S, Jarvis D, Melotti R, et al. Smoking cessation, lung function, and weight gain:a follow-up study. Lancet 2005;365:162935.10.1016/S0140-6736(05)66511-7
  69. 69. Thyagarajan B, Jacobs DR, Apostol GG, et al. Longitudinal association of body mass index with lung function: the CARDIA study. Respir Res 2008;9:31.10.1186/1465-9921-9-31
  70. 70. Pistelli F, Bottai M, Carrozzi L, et al. Changes in obesity status and lung function decline in a general population sample. Respir Med 2008;102:67480.10.1016/j.rmed.2007.12.022
  71. 71. Schikowski T, Schaffner E, Meier F, et al. Improved air quality and attenuated lung function decline: modification by obesity in the SAPALDIA cohort. Environ Health Perspect 2013;121:10349.10.1289/ehp.1206145
  72. 72. Baffi CW, Wood L, Winnica D, et al. Metabolic syndrome and the lung. Chest 2016;149:152534.10.1016/j.chest.2015.12.034
  73. 73. Phelan S, Wadden TA, Berkowitz RI, et al. Impact of weight loss on the metabolic syndrome. Int J Obes 2007;31:14428.10.1038/sj.ijo.0803606
  74. 74. Chinn S, Jarvis D, Melotti R, et al. Smoking cessation, lung function, and weight gain: a follow-up study. Lancet 2005;365:162935.10.1016/S0140-6736(05)66511-7
  75. 75. Fuertes E, Carsin A-E, Antó JM, et al. Leisure-time vigorous physical activity is associated with better lung function: the prospective ECRHS study. Thorax 2018;73:37684.10.1136/thoraxjnl-2017-210947587046229306902
  76. 76. G arcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:45863.10.1164/rccm.200607-896OC
  77. 77. Willemse BWM, Postma DS, Timens W, et al. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004;23:464 710.1183/09031936.04.0001270415065840
  78. 78. Ionas Papassotiriou & Sheikh Mohammed Shariful Islam, Adherence to Mediterranean Diet Is Associated With Lung Function in Older Adults: Data From the Health and Retirement Study, Journal of the American College of Nutrition, ISSN: 0731-5724 (Print) 1541-1087 (Online)
  79. 79. Gutierrez-Carrasquilla L, Sanchez E, Hernandez M, Polanco D, Salas-Salvado J, Betriu A, Gaeta AM, Carmona P, Purroy F, Pamplona R, et al. Effects of mediterranean diet and physical activity on pulmonary function: A cross-sectional analysis in the ILERVAS project. Nutrients. 2019;11(2):32910.3390/nu11020329641322030717453
  80. 80. Rebecca Mc Loughlin, Vanessa Mc Donald, Peter Gibson, Lisa Wood, Weight loss impact on diet quality and eating behaviors for people with obesity and COPD, Nutrients 2017, Oct.10.3390/nu9101147569176329053575
  81. 81. L Kathleen Mahan, Janice L Raymond, “ Krause’s Food and Nutrition care process 2016, 14th edition, 689
  82. 82. Vanessa M Mc Donald, Lisa G Wood, Anne E Holland, Peter Gibson, “ Obesity in COPD: To treat or not to treat ? “ Expert Review of respiratory medicine 2017 vol 11, NO 2, 81-8310.1080/17476348.2017.126757027910701
  83. 83. Ingeborg Farver-Vestergaard, Mia S. O’Toole, Maja O’Connor, Anders Løkke,Elisabeth Bendstrup, Sharee A. Basdeo, Donal J. Cox, Pádraic J. Dunne, Kai Ruggeri, Frances Early, and Robert Zachariae, Mindfulness-based cognitive therapy in COPD: a cluster randomized controlled trial, Eur Respir J 2018; 51: 170208210.1183/13993003.02082-2017
  84. 84. Durrer Schutz et al, “Management of obesity by GP’s” Obesity Facts 2019; 12;40-6610.1159/000496183646569330673677
  85. 85. Stoodley I, Williams L,Thompson C, et al. Evidence for lifestyle interventions in asthma. Breathe 2019; 15: e50-e6110.1183/20734735.0019-2019687614031777565
  86. 86. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. 2018. Available from: https://ginasthma.org
  87. 87. Hirota SA, Janssen LJ. Sodium and asthma: something borrowed, something new? Am J Physiol Lung Cell Mol Physiol 2007; 293: L1369L1373.10.1152/ajplung.00379.200717905852
  88. 88. Guo CH, Liu PJ, Lin KP, et al. Nutritional supplement therapy improves oxidative stress, immune response, pulmonaryfunction, and quality of life in allergic asthma patients: an open-label pilot study. Altern Med Rev 2012; 17: 4256.
  89. 89. Wood LG, Garg ML, Powell H, et al. Lycopene-rich treatments modify noneosinophilic airway inflammation in asthma: proof of concept. Free Radic Res 2008; 42: 94102.10.1080/1071576070176730718324527
  90. 90. Wood LG, Garg ML, Smart JM, et al. Manipulating antioxidant intake in asthma: a randomized controlled trial. Am J Clin Nutr 2012; 96: 534543.10.3945/ajcn.111.03262322854412
  91. 91. McLoughlin RF, Berthon BS, Jensen ME, et al. Short-chain fatty acids, prebiotics, synbiotics, and systemic inflammation: a systematic review and meta-analysis. Am J Clin Nutr 2017; 106: 930945.10.3945/ajcn.117.15626528793992
  92. 92. West CE, Jenmalm MC, Kozyrskyj AL, et al. Probiotics for treatment and primary prevention of allergic diseases and asthma: looking back and moving forward. Expert Rev Clin Immunol 2016; 12: 625639.10.1586/1744666X.2016.114795526821735
  93. 93. van de Pol MA, Lutter R, Smids BS, et al. Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics. Allergy 2011; 66: 3947.10.1111/j.1398-9995.2010.02454.x20716319
  94. 94. Morton AR, Fitch KD. Australian association for exercise and sports science position statement on exercise and asthma J Sci Med Sport 2011; 14: 312316.10.1016/j.jsams.2011.02.009
DOI: https://doi.org/10.2478/inmed-2021-0150 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818
Language: English
Page range: 41 - 58
Published on: Mar 13, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Anca Hâncu, Florin Mihălţan, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.